当前位置:首页 - 行情中心 - 三星医疗(601567) - 财务分析

三星医疗

(601567)

  

流通市值:311.54亿  总市值:311.55亿
流通股本:14.11亿   总股本:14.11亿

三星医疗(601567)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润4.80亿元,每股收益0.35元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益1280824.96万元,未分配利润736345.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产2453022.07万元,负债1172197.10万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入3,630,793,866.3114,600,478,206.1210,433,714,281.296,997,465,533.74
营业总成本3,129,719,427.7312,231,892,536.688,580,662,700.555,848,534,696.67
营业利润567,140,535.342,585,133,167.22,076,643,248.421,315,503,309.8
利润总额568,591,856.182,672,556,622.62,117,707,156.341,358,643,633.59
净利润480,485,140.962,273,237,462.351,822,779,409.651,154,096,908.48
其他综合收益14,203,090.27-3,372,669.31,812,403.5810,108,329.32
综合收益总额494,688,231.232,269,864,793.051,824,591,813.231,164,205,237.8
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计13,652,778,344.6113,799,708,831.4611,269,490,609.4510,396,160,673.02
非流动资产合计10,877,442,319.2410,676,777,755.4710,039,195,179.449,650,870,113.55
资产总计24,530,220,663.8524,476,486,586.9321,308,685,788.8820,047,030,786.57
流动负债合计7,568,086,008.097,810,359,014.987,704,905,672.717,169,271,906.83
非流动负债合计4,153,885,006.624,392,189,417.121,726,260,609.331,591,059,460.38
负债合计11,721,971,014.7112,202,548,432.19,431,166,282.048,760,331,367.21
归属于母公司股东权益合计12,590,896,965.1312,081,698,336.2711,700,018,960.9411,107,937,760.95
股东权益合计12,808,249,649.1412,273,938,154.8311,877,519,506.8411,286,699,419.36
负债和股东权益合计24,530,220,663.8524,476,486,586.9321,308,685,788.8820,047,030,786.57
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计3,034,317,675.116,356,780,728.039,788,478,776.795,991,349,951.05
经营活动现金流出小计3,182,751,953.5814,520,596,284.378,759,266,819.545,731,106,471.94
经营活动产生的现金流量净额-148,434,278.481,836,184,443.661,029,211,957.25260,243,479.11
投资活动现金流入小计3,598,842,167.41,649,942,466.89357,018,810.02271,649,006.38
投资活动现金流出小计4,138,136,988.873,676,681,277.73997,951,195.98562,278,176.43
投资活动产生的现金流量净额-539,294,821.47-2,026,738,810.84-640,932,385.96-290,629,170.05
筹资活动现金流入小计186,824,435.724,168,259,423.7991,114,278.7848,180,446.94
筹资活动现金流出小计90,919,418.464,797,473,280.774,204,190,201.653,670,151,082.05
筹资活动产生的现金流量净额95,905,017.26-629,213,857.07-3,213,075,922.95-2,821,970,635.11
汇率变动对现金及现金等价物的影响48,560,723.57-82,220,480.64-30,405,018.39-42,687,184.47
现金及现金等价物净增加额-543,263,359.12-901,988,704.89-2,855,201,370.05-2,895,043,510.52
期末现金及现金等价物余额3,597,433,814.314,140,697,173.432,187,484,508.272,147,642,367.8
最新报告期:2025-06-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,刘俊,戚腾元,苗雨菲2.072.533.062025-06-05
中信建投朱玥,王在存,贺菊颖,郑博元2.062.53--2025-05-22
国盛证券杨凡仪,杨润思2.062.512.942025-05-11
民生证券王班,乐妍希1.972.392.852025-04-28
中信证券华夏,陈竹,华鹏伟,沈睦钧2.062.432.912025-04-28
TOP↑